medigraphic.com
ISSN 1405-1710 (Print)

2008, Number 1

<< Back Next >>

Rev Cent Dermatol Pascua 2008; 17 (1)

Sclerotherapy

Merino JE, Llergo VRJ

Language: Spanish
References: 25
Page: 11-18
PDF size: 160.97 Kb.


ABSTRACT

The sclerotherapy is the major treatments in smaller vessels of the lower extremities. The sclerotherapy consists in the introduction of a foreign substance in the lumen of blood vessels, causing thrombosis and later fibrosis. Sclerotherapy can improve the cosmetic appearance of aberrant blood vessels and greatly Benefit symptomatic veins by decreasing pain, burning, and cramps that many patients describe. Resolution of larger varicosities can improve the risk of further venous disease sequelae. An understanding of the indications, mechanisms, and treatment management is essential. This article reviews the basics of sclerotherapeutic treatment of the smaller vessels.


REFERENCES

  1. Juárez-Arce V, Hernández-Pérez E. Escleroterapia: revisión del tema. Dermatología Rev Mex 1998; 42: 77-82.

  2. Parsons, Margaret E. Sclerotherapy basics. Dermatol Clin 2004; 22: 501-508.

  3. Goldman M, Bennet R. Treatment of telangiectasia: A review. J Am Acad Dermatol 1987; 17: 167-182.

  4. Weiss R, Weiss M. Sclerotherapy for varicose and telangiectatic veins. In: Dermatology in General Medicine. 5ª edición. Ed Mc Graw-Hill 1999: 2959-2967.

  5. Gardner E. Venas y linfáticos del miembro inferior. En: Anatomía, estudio por regiones del cuerpo humano. 6ª edición. Editorial Salvat. 1992: 232-238.

  6. Moore K. Irrigación de la extremidad inferior. En: Anatomía con orientación clínica. 3ª edición. Editorial médica panamericana 1994: 398-404.

  7. Goldman M, Weiss R, Bergan J. Diagnosis and treatment of varicose veins: A review. J Am Acad Dermatol 1994; 31: 393-413.

  8. Somjen G. Anatomy of the superficial venous system. Dermatol Surg 1995; 21: 35-45.

  9. Tretbar L. Deep Veins. Dermatol Surg 1995; 21: 47-51.

  10. Sadick N. Predisposing factors of varicose and telangiectatic leg veins. J Dermatol Surg Oncol 1992; 18: 883-886.

  11. Folkman J, Klagsburn M. Angiogenic factors. Science 1987; 235: 442-447.

  12. Vin F, Allaert FA, Levardon M. Influence of estrogens and progesterone on the venous system of the lower limbs in women. J Dermatol Surg Oncol 1992; 18: 888-892.

  13. Weiss R. Sclerotherapy of varicose veins of the lower limbs. Dermatol Surg 1996; 22: 883-889.

  14. Weiss R, Goldman M. Advances in Sclerotherapy. Dermatologic Clinics 1995; 13: 431-445.

  15. Butie A. Clinical examination of varicose veins. Dermatol Surg 1995; 21: 52-56.

  16. Kenneth P, Lewix W. Recurrent varicose veins. J Dermatol Surg Oncol 1992; 18: 895-900.

  17. Norris M, Carlin M, Ratz JL. Treatment of essential telangiectasia: Effects of increasing concentrations of polidocanol. J Am Acad Dermatol 1989; 20: 643-649.

  18. Sadick N, Senterfit L, Klein R. The intrinsic antimicrobial activity of selected sclerosing agents in sclerotherapy. Dermatol Surg 1996; 22: 369-371.

  19. Feled C, Jackson J, Bren T et al. Allergic reactions to polidocanol for vein sclerosis. J Dermatol Surg Oncol 1994; 20: 466-468.

  20. Weiss R. Polidocanol: the perfect solution. J Dermatol Surg Oncol 1994; 20: 465.

  21. Martin D, Goldman. A comparison of sclerosing agents: clinical and histologic effects of intravascular sodium tetradecyl sulfate and chromated glycerin in the dorsal rabbit ear vein. J Dermatol Surg Oncol 1990; 16: 18-22.

  22. Gallagher P, Faca F. Varicose veins, primary treatment with sclerotherapy. J Dermatol Surg Oncol 1992; 18: 39-42.

  23. Ocampo-Candiani J, Villareal-Rodríguez A, González-Madrazo R. Escleroterapia. Dermatología Rev Mex 1990; 34: 341-346.

  24. Moreno-González L. Escleroterapia. Dermatología Rev Mex 1991; 35: 245.

  25. Goldman M, Beaudoing D, López et al. Compression in the treatment of leg telangiectasia: a preliminary report. J Dermatol Surg Oncol 1990; 16: 322-325.




2020     |     www.medigraphic.com